DENVER, Sept. 14 /PRNewswire-FirstCall/ — Corgenix Medical
Corporation (OTC Bulletin Board:
CONX), a worldwide developer and marketer of diagnostic test
kits, will host a conference call on Thursday, September 23, 2010,
at 4:00 PM EDT to discuss the Company’s financial and operating
performance for its fiscal year ended June 30, 2010, and the status
of the Company’s product development and marketing activities.
Corgenix invites all those interested in hearing management’s
discussion of the annual results to join the call by dialing:U.S.
attendees: (800) 895-0198International attendees: +1 785 424
1053Conference code is: CORGENIXA question-and-answer session
will follow the presentation by Corgenix management.
A replay will be available for 30 days following the call by
dialing (800) 388-6197 for U.S. participants and +1-402-220-1115
for international participants.
About Corgenix Medical CorporationCorgenix is a leader in the
development and manufacturing of specialized diagnostic kits for
immunology disorders, vascular diseases and bone and joint
disorders, including the world’s only non-blood-based test for
aspirin effect. Corgenix diagnostic products are commercialized for
use in clinical laboratories throughout the world. The company
currently sells over 50 diagnostic products through a global
distribution network and has significant experience advancing
products through the FDA process. More information is available at